Mustang Bio
MBIO
MBIO
55 hedge funds and large institutions have $40.1M invested in Mustang Bio in 2019 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.02% more ownership
Funds ownership: 0.01% → 0.04% (+0.02%)
39% less call options, than puts
Call options by funds: $235K | Put options by funds: $387K
Holders
55
Holding in Top 10
–
Calls
$235K
Puts
$387K
Top Buyers
| 1 | +$12.4M | |
| 2 | +$4.47M | |
| 3 | +$3.45M | |
| 4 |
6CM
683 Capital Management
New York
|
+$2.3M |
| 5 |
Renaissance Technologies
New York
|
+$1.65M |
Top Sellers
| 1 | -$74K | |
| 2 | -$30.3K | |
| 3 | -$11K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$4.66K |